WO2019020726A1 - Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis - Google Patents

Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis Download PDF

Info

Publication number
WO2019020726A1
WO2019020726A1 PCT/EP2018/070242 EP2018070242W WO2019020726A1 WO 2019020726 A1 WO2019020726 A1 WO 2019020726A1 EP 2018070242 W EP2018070242 W EP 2018070242W WO 2019020726 A1 WO2019020726 A1 WO 2019020726A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
group
ringa
independently
different
Prior art date
Application number
PCT/EP2018/070242
Other languages
French (fr)
Inventor
Christoph Taeschler
Florencio Zaragoza Doerwald
Stefan Ellinger
Matthias Beller
Helfried Neumann
Florian WENIGER
Original Assignee
Lonza Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ltd filed Critical Lonza Ltd
Priority to CN201880049832.9A priority Critical patent/CN110944965A/en
Priority to JP2020504193A priority patent/JP7219752B2/en
Priority to US16/632,572 priority patent/US10968187B2/en
Priority to EP18745613.2A priority patent/EP3645484B1/en
Priority to CA3070021A priority patent/CA3070021A1/en
Priority to KR1020207005703A priority patent/KR20200035097A/en
Publication of WO2019020726A1 publication Critical patent/WO2019020726A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B37/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving either the formation of a carbon-to-carbon bond between two carbon atoms not directly linked already or the disconnection of two directly linked carbon atoms
    • C07B37/04—Substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C07C17/266—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions of hydrocarbons and halogenated hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/32—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by introduction of halogenated alkyl groups into ring compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01—Preparation of ethers
    • C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/12—Radicals substituted by halogen atoms or nitro or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Definitions

  • the invention discloses a method for preparation of alkylated, fluoro alkylated, chloro alkylated and fluorochloro alkylated compounds by a heterogeneous Co-catalysed alkylation or fluoro, chloro and fluorochloro alkylation with alkyl halides, fluoro alkyl halides, chloro alkyl halides or fluorochloro alkyl halides respectively.
  • Organo fluorine chemistry plays an important role in medicinal, agricultural, and material sciences and fields.
  • Haloalkyl groups have strong effects on the properties of compounds such as stability and lipophilicity, and in addition, long chain haloalkyl groups, in particular fluoroalkyl groups provide high water- and oil-resistance and low friction.
  • homogeneous catalysis suffers from the inherent problems associated with homogeneous catalyzed reactions due to the use of unrecoverable catalysts comprising metals and ligands.
  • unrecoverable catalysts comprising metals and ligands.
  • inconveniences with regard to catalyst handling, recyclability, and separation of the catalyst from products impede the transfer of these approaches to large-scale industrial processes.
  • expensive and structurally complicated ligands are required in homogeneous catalysis, which are often not commercially available for use on industrial scale.
  • EP 0 114 359 Al discloses a process for the manufacture of perfluoralkyl substituted carbocyclic or heterocyclic compounds by reaction of perfluoroalkyl iodides with unsubstituted or substituted carbocyclic or heterocyclic compounds at elevated temperatures and in presence of at least one alkaline salt, characterized by carrying out the reaction in the presence of at least one metal of the first or eight auxiliary group of the periodic table or in the presence of a complex compound containing said metal as the central atom.
  • WO 93/16969 A discloses a process for the catalytic perfluoro alkylation of aromatic compounds, wherein a perfluoroalkyl iodide or mixture of iodides is reacted with an aromatic compound in the presence of an aqueous base, such as an alkali metal hydroxide or carbonate, and discloses that further improvements in rate and yield are secured by employing, as the catalyst, a noble metal supported on porous silica microspheres.
  • EP 1 947 092 Al discloses perfluoroalkylation of nucleobases with a perfluoroalkyl halide in the presence of a sulfoxide, a peroxide and an iron compound.
  • a specifically mentioned catalytic system is a Fe2(S04)3/H2S04 H 2 02 system.
  • WO 2015/185677 Al describes a method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous catalysis using a Pt/C-catalyst in the presence of CS2CO3 or CSHCO3. While the use of a Pt/C-catalyst allows for heterogeneous catalysis, Pt is an expensive metal resulting in considerable costs for the manufacturing process of alkylated or haloalkylated compounds on an industrial scale.
  • the method should be applicable to a wide variety of substrates and should be compatible with a wide variety of functional groups. Furthermore the method should not be restricted to iodides as alkylating agent only, but should also work with other halides in particular with bromides. And the method should work not only with perfluorinated alkyl halides, but also with fluorinated and chlorinated alkyl halides. Furthermore, since noble metal catalysts used so far are expensive, a catalyst system which works effectively without noble metal is desired.
  • a substrate herein also called COMPSUBST
  • COMPSUBST is reacted in the presence of CAT with a halide, the alkylating agent, herein also called ALKHAL, to introduce an alkyl, fluoro alkyl, chloro alkyl or fluorochloro alkyl residue into COMPSUBST and thereby forming the product which is an alkylated, fluoro alkylated, chloro alkylated or fluorochloro alkylated compound, herein also called AL YLCOMPSUBST.
  • AL YLCOMPSUBST alkylating agent
  • Co-Ll/C as catalyst provides unexpected advantages.
  • the catalyst can be reused and is not deactivated by the reaction.
  • the method is applicable both to aromatic and non-aromatic compounds.
  • heterocyclic compounds can be converted, even nonactivated thiophenes react smoothly at comparably low temperatures.
  • a particular advantage of the method according to the invention is that not only iodides can be used as alkylating agent, that is as ALKHAL, but that also good results are obtained with bromides as alkylating agent. It was surprisingly found that also when using bromides as ALKHAL high selectivites and high yields were obtained, also with different substrates, by use of the catalyst Co- Ll/C. This has essential advantages in practice as the bromides are significantly more favorable compared to the iodides and therefore the method can be carried out much more efficiently. Further, side products emerging from the use of iodides are more difficult to dispose.
  • alkyl linear or branched alkyl; preferably linear alkyl
  • R34, R28 and R38 are identical or different and independently from each other selected from the group consisting of is used synonymously with "R24, R34, R28 and R38 at each occurrence are identical or different and independently from each other selected from the group consisting of
  • halogen or halo F, CI, Br or I preferably F, CI or Br; more preferably F or CI;
  • Co-Ll/C cobalt 1,10-phenanthroline supported on carbon, to be more precise it is cobalt oxide supported on 1,10-phenanthro line/carbon and can therefore also be abbreviated with C03O4-LI/C;
  • TEA triethylamine wt%, “% by weight” and “weight-%” are used synonymously and mean percent by weight.
  • Subject of the invention is a method for the preparation of an alkylated, fluoro alkylated, chloro alkylated or fluorochloro alkylated compound ALKYLCOMPSUBST with heterogeneous catalysis by a reaction of a compound COMPSUBST with an alkylating agent ALKHAL in the presence of a catalyst CAT;
  • ALKHAL is a compound of formula (III);
  • X is Br or I
  • R3 is Ci-20 alkyl
  • Ci-20 alkyl residue R3 of ALKHAL is either unsubstituted, or at least one hydrogen residue of the Ci-20 alkyl residue R3 of ALKHAL is substituted by F or CI;
  • CAT is Co-Ll/C
  • LI 1,10-phenanthroline
  • COMPSUBST is selected from the group consisting of a compound COMPSUBST-I, compound of formula (II), compound of formula (IV), polystyrene, ethene and ethine; wherein
  • COMPSUBST-I is a ring RINGA or is a RINGA condensed with a ring RINGB;
  • RINGA is a 5 or 6 membered carbocyclic or heterocyclic ring
  • RINGA when RINGA is a heterocyclic ring, then RINGA has 1 , 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N, O and S;
  • RINGA when RINGA is a 5 membered ring, then RINGA is unsubstituted or substituted by 1 , 2, 3 or 4 identical or different subsitutents,
  • RINGA when RINGA is a 6 membered ring then RINGA is unsubstituted or substituted by 1, 2, 3, 4 or
  • any of said subsitutents of RINGA is independently from any other of said substitutent of
  • RINGA selected from the group consisting of Ci-10 alkyl, C3-8 cycloalkyl, C1-4 alkoxy, OH, N(R10)R1 1 , CN, NH-OH, NO, N0 2 , F, CI, Br, I, CF 3 , (CH 2 ) m -C(0)Yl, S(O) 2 R50,
  • CH C(H)R28, C ⁇ C-R24 ; benzyl, phenyl and naphthyl;
  • RINGB is a 5 or 6 membered carbocyclic or heterocyclic ring, resulting in a bicyclic having 8,
  • RINGB when RINGB is a heterocyclic ring, then RINGB contains 1 , 2 or 3 identical or different
  • endocyclic heteroatoms independently from each other selected from the group consisting of N, O and S;
  • any of said benzyl, phenyl and naphthyl substitutent of RINGA or RINGB is independently from each other unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, C1-4 alkoxy, N0 2 and CN; m and n are identical or different and independently from each other an integer from 0 to 10; wherein
  • R40 and R41 are identical or different and independently from each other selected from the group consisting of -(CH 2 ) q -C(0)R13 and -CN;
  • R42 is selected from the group consisting of -(CH 2 ) q -C(0)R13, -CN and R13;
  • q is independently an integer from 0 to 10;
  • any of the R14, R15 and R16 are identical or different and independently from each other selected from the group consisting of H, F, CI and Br; any of the RIO, Rl 1, R17, R18, R19 and R20 are identical or different and are independently from each other H or Ci-e alkyl, or RIO and Rl 1, R17 and R18 or R19 and R20 represent together tetramethylene or pentamethylene.
  • X is Br.
  • RINGA when RINGA is a heterocyclic ring, then RINGA has 1 , 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N and S.
  • RINGB when RINGB is a heterocyclic ring, then RINGB contains 1, 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N and S.
  • RINGA is an aromatic ring.
  • RINGB is an aromatic ring.
  • RINGA and RINGB are aromatic rings.
  • COMPSUBST is selected from the group consisting of COMPSUBST-I,
  • COMPSUBST-I, ethene and the ethine are as defined herein, also with all their
  • COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is
  • COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is selected from the group consisting of
  • COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is selected from the group consisting of
  • COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is selected from the group consisting of
  • COMPSUBST-I is RINGA and is selected from the group consisting of
  • COMPSUBST-I is RINGA and is selected from the group consisting of
  • RINGA or RINGA condensed with RINGB being unsubstituted or substituted by 1, 2, 3 or 4 in case of RINGA being a monocyclic compound with 5 endocyclic atoms, by 1, 2, 3, 4 or 5 in case of RINGA being a monocyclic compound with 6 endocyclic atoms, by 1, 2, 3, 4, 5 or 6 in case of RINGA condensed with RINGB being a bicyclic compound wherein a 5-membered and a 6-membered ring are ortho-fused,
  • Ci-io alkyl substitutent is unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, OH, 0-C(0)-Ci-5 alkyl, O-Ci-io alkyl, S-Ci-10 alkyl, S(0)-Ci-io alkyl, S(0 2 )-Ci-io alkyl, O-Ci-e alkylen-O-Ci-e alkyl, C3-8 cycloalkyl and 1,2,4-triazolyl;
  • said benzyl, phenyl and naphthyl substitutent is independently from each other unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, CM alkoxy, N0 2 and CN;
  • RIO and Rl 1 are identical or different and are independently from each other H or Ci-6 alkyl or RIO and Rl 1 represent together a tetramethylene or a pentamethylene group;
  • R24 and R28 are identical or different and are independently from each other OH, Ci-io alkyl, C(R25)(R26)-0-R27, with R25, R26 and R27 being identical or different and indepedently from each other being H or C 1-10 alkyl;
  • R50 is OH, Ci-6 alkyl or C 1-6 alkoxy
  • Yl is H, OH, C (R14) (R15) R16, Ci-e alkyl, O-Ci 6 , phenyl, benzyl, O-phenyl, O-G 6 alkylen-O- C1-6 alkyl or N (R19) R20 with R14, R15, R16 being identical or different and independently from each other H, F, CI or Br;
  • R19 and R20 being identical or different and are independently from each other H or Ci-6 alkyl or R19 and R20 represent together a tetramethylene or a pentramethylene group;
  • n is independently an integer from 0 to 10.
  • m, n, p and q are identical or different and independently from each other an integer 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; more preferably at each occurence, m, n, p and q are identical or different and independently from each other an integer from 0 to 4 and in particular 0, 1, 2, 3 or 4;
  • m, n, p and q are independently 0 or 4.
  • Yl, Y2 and R13 are identical or different and
  • Yl, Y2 and R13 are identical or different and independently from each other selected from the group consisting of H, OH, C 1-2 alkyl, and O-C1-2 alkyl.
  • RINGA or RINGA condensed with RINGB is unsubstituted or substituted
  • Ci-4 alkyl substitutent is unsubstituted or substituted with 1, 2 or 3 identical or different
  • COMPSUBST is selected from the group consisting of benzene, pyrazole,
  • Yl, RIO, Rl 1, m, R50, R28 and R24 are as defined herein, also with all their embodiments; preferably, Yl and Rl independently are Ci-6 alkyl or O- Ci-6 alkyl.
  • COMPSUBST is selected from the group consisting of
  • Yl, RIO, Rl 1, m, R50, R28 and R24 are as defined herein, also with all their embodiments; preferably, Yl and Rl independently are Ci-6 alkyl or O-Ci-6 alkyl.
  • COMPSUBST is selected from the group consisting of
  • Yl is as defined herein, also with all their embodiments; preferably, Yl is d_6 alkyl or O-Ci 6 alkyl;
  • Yl is methyl, ethyl, methoxy
  • COMPSUBST is selected from the group consisting of
  • COMPSUBST is selected from the rou consistin of
  • COMPSUBST is selected from the group consisting of
  • COMPSUBST is a compound of formula (II), or a compound of formula (IV), wherein als residues are defined as above, also with all their embodiments.
  • Ci-io alkyl consisting of Ci-io alkyl, C 3 -e cycloalkyl, C alkoxy, N(R10)R1 1, CN, F, CI, Br, I, CF 3 ,
  • an ethine which is unsubstituted or substituted by 1 substitutent selected from the group consisting of CLIO alkyl, C 3 _ 6 cycloalkyl, C alkoxy, N(R10)R11, CN, F, CI, Br, I, CF 3 , (CH 2 ) m -C(0)Yl,
  • the ethene is unsubstituted or substituted by 1 or 2 substitutents selected from the group consisting of CMO alkyl, CM alkoxy, N(R10)R11, CN, F, CI, Br, I, CF 3 , (CH 2 ) m -
  • the ethine being unsubstituted or substituted by 1 substitutent selected from the group consisting of CMO alkyl, CM alkoxy, N(R10)R11, CN, F, CI, Br, I, CF 3 , (CH 2 ) m -
  • RIO, Rl 1 , m, Yl and R50 as defined above, also with all their embodiments.
  • Embodiments of the substituted ethene are propene, ethene- 1,1-diyldibenzene and 3,3-dimethylbut- 1-ene.
  • An embodiment of the substituted ethine is 1-octyne.
  • COMPSUBST is selected from a compound of formula (V) or a compound of formula (VI)
  • R43 is H or CH 3 ;
  • R44 is selected from the group consisting of Ci-io alkyl, C alkoxy, OH, N(R10)R11, CN, NO,
  • RIO, Rl 1, m, Yl and R50 as defined above, also with all their embodiments.
  • ALKHAL is a compound of formula (III);
  • X is Br or I; preferably X is Br;
  • R3 is Ci-20 alkyl or a Ci-20 alkyl wherein in the alkyl chain at least one hydrogen is substituted by F or CI, preferably by F;
  • R3 is Ci-15 alkyl or Ci-15 alkyl wherein in the alkyl chain at least one hydrogen is substituted by F or CI, preferably by F;
  • R3 is Ci-10 alkyl or Ci-10 alkyl wherein in the alkyl chain at least one hydrogen is substituted by F or CI, preferably by F.
  • R3 is Ci-20 alkyl, more especially Ci-15 alkyl, even more especially Ci-10 alkyl, wherein all hydrogen atoms are independently substituted by CI or F,
  • the alkyl is a linear perfluoro alkyl.
  • X is Br or I
  • X is I
  • X is Br
  • ALKHAL is a perfluoroalkyl halide, F2HC-CI or F2HC-Br, preferably
  • ALKHAL is a perfluoroalkyl bromide or iodide, F2HC-CI or F2HC-Br;
  • X is Br or I
  • R3 is perfluoro Ci-20 alkyl, or
  • ALKHAL is F 2 HC-C1 or F 2 HC-Br;
  • X is Br or I
  • R3 is perfluoro Ci-15 alkyl, or
  • ALKHAL is F 2 HC-C1 or F 2 HC-Br;
  • X is Br or I
  • R3 is perfluoro Ci-10 alkyl, or
  • ALKHAL is F2HC-CI or F 2 HC-Br.
  • ALKHAL is selected from the group consisting of F21G0-I, FnCs-I, F13C6-I, F9C4-I, F3C-I, F 2 iCio-Br, FnCg-Br, Fi 3 C 6 -Br, F 9 C 4 -Br, F 3 C-Br, F3C-CI, F2HC-CI, and F 2 HC-Br; more in particular, ALKHAL is selected from the group consisting of n-F2iGo-I, n-FnCs-I, n- Fi 3 C 6 -I, n-F 9 C 4 -I, F3C-I, n-F 2 iCio-Br, n-F n C 8 -Br, n-Fi 3 C 6 -Br, n-F 9 C 4 -Br, F 3 C-Br, F3C-CI,
  • ALKHAL is selected from the group consisting of F21C10-I,
  • ALKHAL is selected from the group consisting of n-F2iGo-I, n-FnCs-I, n-Fi3C6-I, n-
  • ALKHAL is selected from the group consisting of F2iGo-Br,
  • reaction is performed in the presence of or using a catalyst CAT, CAT is Co-Ll/C, which is cobalt 1 ,10-phenanthroline supported on carbon,
  • CAT is cobalt 1 ,10-phenanthroline supported on graphene.
  • Co-Ll/C can be prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al, Nature Chemistry, 2013, 5, 537-543, especially as described schematically in Figure 1 therein, that is by reacting Co(OAc)2 . 4 H 2 0 with 1 , 10-phenantroline and thereby forming a complex Co (phen)2(OAc) 2 which is then absorbed on carbon black and kept e.g. at 800 °C for 2 h under argon to provide Co-Ll/C, which contains cobalt oxide supported on 1,10- phenantroline/carbon black.
  • the amount of Co in CAT is from 0.1 to 20 %, more preferably from 0.5 to 15 %, even more preferably from 1 to 12.5 %, especially from 2 to 12.5 %, the % are % by weight and are based on the total weight of CAT.
  • the amount of Co in the reaction is from 0.001 to 20 %, more preferably from 0.01 to 15 %, even more preferably from 0.025 to 12.5%, especially from 0.05 to 10%, the % are % by weight % and are based on the weight of ALKHAL.
  • the mol equivalents are based on the molar amount of ALKHAL.
  • the reaction temperature of the reaction is preferably from 20 to 200°C, more preferably from 20 to 150°C, even more preferably from 40 to 150°C, especially from 70 to 150°C, more especially from 70 to 140°C, even more especially from 100 to 140°C.
  • the reaction time of the reaction is preferably from 30 min to 72 h, more preferably from 6 h to 60 h, even more preferably from 10 h to 55 h.
  • the reaction is done in the presence of a base BAS
  • BAS is selected from the group consisting of Cs 2 C0 3 , CsHCOs, K2CO3, K3PO4, K2HPO4, KOAc, KOH, Mg(OH) 2 , TEA, DBU, and HNEt 2 .
  • BAS is selected from the group consisting of CS2CO3, K2CO3, K3PO4, K2HPO4, KOAc, KOH, Mg(OH) 2 , TEA, DBU, and HNEt 2 .
  • BAS is CS2CO3 or K2CO3;
  • BAS is CS2CO3.
  • the amount of BAS in the reaction is from 0.1 to 10 mol equivalents, more preferably 0.5 to 5 mol equivalents, even more preferably from 0.75 to 2.5 mol equivalents, the mol equivalents are based on the molar amount of ALKHAL.
  • the reaction is done under inert atmosphere.
  • the inert atmosphere is achieved by the use of an inert gas preferably selected from the group consisting of argon, another noble gas, lower boiling alkane, nitrogen and mixtures thereof.
  • the lower boiling alkane is preferably a C 1-3 alkane, i.e. methane, ethane or propane.
  • the reaction can be done in a closed system, or it can be done at a pressure caused by the chosen temperature in a closed system. It is also possible to apply pressure with said inert gas. It is also possible to carry out the reaction at ambient pressure.
  • ALKHAL is a gaseous substance, e.g. in case of CF 3 Br
  • ALKHAL can be used for applying the desired pressure, e.g. when charging ALKHAL.
  • the reaction is done at a pressure of from 1 to 1000 bar, more preferably of from 1 to 500 bar, even more preferably of from 1 to 200 bar, especially of from 1 to 100 bar, more especially of from 1 to 50 bar.
  • ALKHAL is a gaseous substance, e.g. in case of CF 3 Br
  • pressure is applied, then preferably the reaction is done at a pressure of from 2 to 1000 bar, more preferably of from 2 to 500 bar, even more preferably of from 2 to 200 bar, especially of from 2 to 100 bar, more especially of from 2 to 50 bar.
  • vapour pressure of CF 3 Br at ambient temperature is around 14 bar, so when CF 3 Br is used as ALKHAL, then preferably the reaction is done initially at a pressure of 14 bar or higher.
  • the reaction can be done by using a solvent SOL.
  • SOL is preferably selected from the group consisting of alkanes, chlorinated alkanes, ketones, ethers, esters, aliphatic nitrils, aliphatic amides, sulfoxides, and mixtures thereof.
  • SOL is selected from the group consisting of C5-8 alkane, C5-C10 cycloalkane, chlorinated Ci-s alkane, acetone, methylethylketone (MEK), diethylketone, methyl tert-butyl ether (MTBE), tetrahydrofuran (THF), methyltetrahydrofuran, ethylacetate, butylacetate, valeronitril, acetonitrile, dimethylformamide (DMF), dimethylacetamide, N-methylpyrrolidone (NMP), dimethylsulfoxide (DMSO), dioxaneisopropanol, and mixtures thereof.
  • MMF dimethylformamide
  • NMP N-methylpyrrolidone
  • DMSO dimethylsulfoxide
  • SOL is selected from the group consitsing of acetone, MEK, heptane, cyclohexane, DMSO, dichloromethane, ethylacetate, dimethylacetamide, DMF, dioxane, THF, isopropanol, NMP, and mixtures thereof.
  • SOL is acetone or methylethylketone;
  • SOL is acetone
  • COMPSUBST simultaneously as substrate and as solvent.
  • reaction can also be carried out in the absence of a solvent, i.e. "in substance".
  • a solvent i.e. "in substance”.
  • COMPSUBST serves as solvent. This procedure is in particular applicable for compounds COMPSUBST being liquid at room temperature or having a low melting point of less than 40 °C.
  • the amount of SOL is preferably from 0.1 to 100 fold, more preferably from 1 to 50 fold, even more preferably from 1 to 25 fold, especially from 1 to 15 fold of the weight of ALKHAL.
  • ALKYLCOMPSUBST can be isolated by standard methods such as evaporation of volatile components, extraction, washing, drying, concentration, crystallization, chromatography and any combination thereof, which are known per se to the person skilled in the art.
  • COMPSUBST, CAT, ALKHAL and BAS are commercially available and can be prepared according to known precedures.
  • the reaction is done in the presence of a compound COMPSALT
  • COMPSALT is selected from the group consisting of Nal, KJ, Csl, NaBr, KBr, CsBr,
  • R30, R31, R32 and R33 are identical or different and independently from each other selected from the group consisting of H and Ci-io alkyl;
  • R30, R31, R32 and R33 are identical or different and independently from each other selected from the group consisting of H and C2-6 alkyl;
  • COMPSALT is selected from the group consisting of Nal, (n-Bu)4NI, NaBr, and
  • the reaction is preferably done in the presence of a compound COMPSALT and X is Br.
  • Conversion as used herein is calculated from the molar amount of the remaining ALKHAL( e.g. determining quantitative GC analysis with hexadecane as internal standard), in particular conversion denote the amount of ALKHAL which has reacted during the reaction.
  • Selectivity denotes the molar amount of the desired product ALKYLCOMPSUBST based on reacted starting material.
  • the gas atmosphere in the pyrex tube was flushed with nitrogen, the tube was closed with a screw cap and heated with stirring for the reaction time as stated, preferably for 24 h, at the reaction temperature as stated, preferably at 130°C.
  • the resulting mixture was cooled to room temperature and diluted with dichloromethane, ether or methanol (10ml).
  • the solids were removed by centrifugation (3000 rpm, 15 min) or by filtration.
  • the obtained product solution was analyzed by quantitative GC analysis (internal standard hexadecane) or 19F-NMR analysis using the internal standards 1 ,2-difiuorobenzene or 1,4-difluorobenzene.
  • Protocoll 3 General Procedure 3 "in substance" with ALKHAL which is gaseous at ambient temparture
  • a mixture of the substrate COMPSUBST (1 eq, 2.5 mmol), Co-Ll/C (10 mol%, 0.25 mmol, 0.49 g, 3 wt% Co/C, prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al., Nature Chemistry, 2013, 5, 537-543), and Cs 2 C0 3 (1.1 eq, 2.5 mmol, 0.894 g) was placed in a magnetically stirred Parr autoclave (Parr Instruments 4560 series). After replacing the air in the autoclave with nitrogen, ALKHAL gas was used to increase the pressure in the autoclave to 15 bars, the autoclave was sealed and heated at 130°C for 48 h with stirring.
  • Protocoll 4 General Procedure 4 "in solution” with ALKHAL which is gaseous at ambient temparture
  • ALKHAL gas was used to increase the pressure in the autoclave to 15 bars, the autoclave was sealed and heated at 130°C for 48 h with stirring. After cooling the reaction mixture to room temperature, the pressure was released from the autoclave, the reaction mixture diluted with 25 ml diethylether and 1 ,2-difluorobenzene (300 mg) was added as an internal standard. The solids were removed by centrifugation (3000 rpm, 15 min) or filtration. An aliquot was taken for quantitative GC-MS and 19 F-NMR analysis. The filtrate was concentrated under reduced pressure and the product isolated by column chromatography and gradient elution (1. pentane (100%, 10ml) 2. pentane : diethylether (1 : 1 v/v, 10 ml)) to give the product ALKYLCOMPSUBST.
  • ALKHAL has a linear chain, if not otherwise stated.
  • CS means COMPSUBST.
  • AH means ALKHAL.
  • IS means isomer(s).
  • Reactuion time was 16 h, except for entry 6, where the reaction time was 20 h.
  • BAS was Cs 2 C0 3 .
  • CAT was 5 wt% Co-Ll/C.
  • Any alkyl chain is a linear alkyl chain, if not otherwise stated.

Abstract

The invention discloses a method for preparation of alkylated, fluoro alkylated, chloro alkylated and fluorochloro alkylated compounds by a heterogeneous Co-catalysed alkylation or fluoro, chloro and fluorochloro alkylation with alkyl halides, fluoro alkyl halides, chloro alkyl halides or fluorochloro alkyl halides respectively.

Description

METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS COBALT
CATALYSIS
The invention discloses a method for preparation of alkylated, fluoro alkylated, chloro alkylated and fluorochloro alkylated compounds by a heterogeneous Co-catalysed alkylation or fluoro, chloro and fluorochloro alkylation with alkyl halides, fluoro alkyl halides, chloro alkyl halides or fluorochloro alkyl halides respectively.
BACKGROUND OF THE INVENTION
Organo fluorine chemistry plays an important role in medicinal, agricultural, and material sciences and fields. Haloalkyl groups have strong effects on the properties of compounds such as stability and lipophilicity, and in addition, long chain haloalkyl groups, in particular fluoroalkyl groups provide high water- and oil-resistance and low friction.
There have been various approaches to provide alkylated or haloalkylated compounds by homogeneous catalysis. However homogeneous catalysis suffers from the inherent problems associated with homogeneous catalyzed reactions due to the use of unrecoverable catalysts comprising metals and ligands. In particular inconveniences with regard to catalyst handling, recyclability, and separation of the catalyst from products, impede the transfer of these approaches to large-scale industrial processes. Furthermore expensive and structurally complicated ligands are required in homogeneous catalysis, which are often not commercially available for use on industrial scale.
EP 0 114 359 Al discloses a process for the manufacture of perfluoralkyl substituted carbocyclic or heterocyclic compounds by reaction of perfluoroalkyl iodides with unsubstituted or substituted carbocyclic or heterocyclic compounds at elevated temperatures and in presence of at least one alkaline salt, characterized by carrying out the reaction in the presence of at least one metal of the first or eight auxiliary group of the periodic table or in the presence of a complex compound containing said metal as the central atom.
WO 93/16969 A discloses a process for the catalytic perfluoro alkylation of aromatic compounds, wherein a perfluoroalkyl iodide or mixture of iodides is reacted with an aromatic compound in the presence of an aqueous base, such as an alkali metal hydroxide or carbonate, and discloses that further improvements in rate and yield are secured by employing, as the catalyst, a noble metal supported on porous silica microspheres. EP 1 947 092 Al discloses perfluoroalkylation of nucleobases with a perfluoroalkyl halide in the presence of a sulfoxide, a peroxide and an iron compound. A specifically mentioned catalytic system is a Fe2(S04)3/H2S04 H202 system.
WO 2015/185677 Al describes a method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous catalysis using a Pt/C-catalyst in the presence of CS2CO3 or CSHCO3. While the use of a Pt/C-catalyst allows for heterogeneous catalysis, Pt is an expensive metal resulting in considerable costs for the manufacturing process of alkylated or haloalkylated compounds on an industrial scale.
Therefore there was a need for a heterogeneously catalyzed process for the preparation of alkylated or haloalkylated and in particular of perfluoroalkylated compounds, which provides high yields. The method should be applicable to a wide variety of substrates and should be compatible with a wide variety of functional groups. Furthermore the method should not be restricted to iodides as alkylating agent only, but should also work with other halides in particular with bromides. And the method should work not only with perfluorinated alkyl halides, but also with fluorinated and chlorinated alkyl halides. Furthermore, since noble metal catalysts used so far are expensive, a catalyst system which works effectively without noble metal is desired.
Surprisingly, these requirements could be achieved by the method according to the present invention, which uses as catalyst, herein also called CAT, also abbreviated with Co-Ll/C, a cobalt 1,10-phenanthroline supported on carbon, LI is 1,10-phenanthroline.
Co-Ll/C and its preparation is described in Westerhaus et al., Nature Chemistry, 2013, 5, 537-543, especially in Figure 1 therein, and in the supplementary information to this article, available under DOI: 10.1038/NCHEM.1645, under chapter "SI . Catalyst preparation".
According to the present invention a substrate, herein also called COMPSUBST, is reacted in the presence of CAT with a halide, the alkylating agent, herein also called ALKHAL, to introduce an alkyl, fluoro alkyl, chloro alkyl or fluorochloro alkyl residue into COMPSUBST and thereby forming the product which is an alkylated, fluoro alkylated, chloro alkylated or fluorochloro alkylated compound, herein also called AL YLCOMPSUBST.
The use of Co-Ll/C as catalyst provides unexpected advantages. In particular the catalyst can be reused and is not deactivated by the reaction. The method is applicable both to aromatic and non-aromatic compounds. Also heterocyclic compounds can be converted, even nonactivated thiophenes react smoothly at comparably low temperatures.
A particular advantage of the method according to the invention is that not only iodides can be used as alkylating agent, that is as ALKHAL, but that also good results are obtained with bromides as alkylating agent. It was surprisingly found that also when using bromides as ALKHAL high selectivites and high yields were obtained, also with different substrates, by use of the catalyst Co- Ll/C. This has essential advantages in practice as the bromides are significantly more favorable compared to the iodides and therefore the method can be carried out much more efficiently. Further, side products emerging from the use of iodides are more difficult to dispose.
Further, due to the use of a cobalt containing catalyst instead of a nobel metal catalyst, considerable cost savings are achieved.
In this text, the following meanings are used, if not otherwise stated:
alkyl linear or branched alkyl; preferably linear alkyl;
"any of the" is used synonymously with "at each occurrence", for example "any of the R24,
R34, R28 and R38 are identical or different and independently from each other selected from the group consisting of is used synonymously with "R24, R34, R28 and R38 at each occurrence are identical or different and independently from each other selected from the group consisting of
DBU l,8-diazabicyclo[5.4.0]undec-7-en;
halide F", CI", Br" or Γ; preferably CI", Br", and Γ; more preferably Br" and Γ; even more preferably Br";
halogen or halo F, CI, Br or I; preferably F, CI or Br; more preferably F or CI;
FIRMS EI High Resolution Mass Spectrometry Electron Impact;
"linear" and "n-" are used synonymously with respect to the respective isomers of alkanes;
LI 1,10-phenanthroline;
Co-Ll/C cobalt 1,10-phenanthroline supported on carbon, to be more precise it is cobalt oxide supported on 1,10-phenanthro line/carbon and can therefore also be abbreviated with C03O4-LI/C;
RT room temperature, it is used synonymously with the expression ambient
temperature;
TEA triethylamine; "wt%", "% by weight" and "weight-%" are used synonymously and mean percent by weight.
SUMMARY OF THE INVENTION
Subject of the invention is a method for the preparation of an alkylated, fluoro alkylated, chloro alkylated or fluorochloro alkylated compound ALKYLCOMPSUBST with heterogeneous catalysis by a reaction of a compound COMPSUBST with an alkylating agent ALKHAL in the presence of a catalyst CAT;
ALKHAL is a compound of formula (III);
R3-X (III) wherein
X is Br or I;
R3 is Ci-20 alkyl;
wherein the Ci-20 alkyl residue R3 of ALKHAL is either unsubstituted, or at least one hydrogen residue of the Ci-20 alkyl residue R3 of ALKHAL is substituted by F or CI;
CAT is Co-Ll/C;
LI is 1,10-phenanthroline;
COMPSUBST is selected from the group consisting of a compound COMPSUBST-I, compound of formula (II), compound of formula (IV), polystyrene, ethene and ethine; wherein
COMPSUBST-I is a ring RINGA or is a RINGA condensed with a ring RINGB;
RINGA is a 5 or 6 membered carbocyclic or heterocyclic ring,
when RINGA is a heterocyclic ring, then RINGA has 1 , 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N, O and S;
when RINGA is a 5 membered ring, then RINGA is unsubstituted or substituted by 1 , 2, 3 or 4 identical or different subsitutents,
when RINGA is a 6 membered ring then RINGA is unsubstituted or substituted by 1, 2, 3, 4 or
5 identical or different subsitutents,
any of said subsitutents of RINGA is independently from any other of said substitutent of
RINGA selected from the group consisting of Ci-10 alkyl, C3-8 cycloalkyl, C1-4 alkoxy, OH, N(R10)R1 1 , CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50,
CH=C(H)R28, C≡C-R24 ; benzyl, phenyl and naphthyl;
RINGB is a 5 or 6 membered carbocyclic or heterocyclic ring, resulting in a bicyclic having 8,
9 or 10 ring members in total,
when RINGB is a heterocyclic ring, then RINGB contains 1 , 2 or 3 identical or different
endocyclic heteroatoms independently from each other selected from the group consisting of N, O and S;
RINGB is unsubstituted or substituted with 1 , 2 or 3 identical or different substituents in case of RINGB being a 5 membered ring, with 1 , 2, 3 or 4 identical or different substituents in case of RINGB being a 6 membered ring, which identical or different substitutents are independently from each other selected from the group consisting of Ci-io alkyl, C3-8 cycloalkyl, CM alkoxy, OH, N(R17)R18, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)„-C(0)Y2, S(0)2R51, CH=C(H)R38, C≡C-R34 } benzyl, phenyl and naphthyl; any of said Ci-io alkyl substitutent of RFNGA or RINGB is unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, OH, 0-C(0)-Ci-s alkyl, O-CMO alkyl, S-G-io alkyl, S(0)-G-io alkyl, S(02)-Ci-io alkyl, O-Ci-6 alkylen-O-G-6 alkyl, C3-8 cycloalkyl and 1,2,4-triazolyl;
any of said benzyl, phenyl and naphthyl substitutent of RINGA or RINGB is independently from each other unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, C1-4 alkoxy, N02 and CN; m and n are identical or different and independently from each other an integer from 0 to 10; wherein
the compound of formula (II) and the compound of formula (IV) being
Figure imgf000006_0001
R40 and R41 are identical or different and independently from each other selected from the group consisting of -(CH2)q-C(0)R13 and -CN;
R42 is selected from the group consisting of -(CH2)q-C(0)R13, -CN and R13;
q is independently an integer from 0 to 10; wherein
the ethene being unsubstituted or substituted by 1, 2 or 3 substitutents selected from the group consisting of G-io alkyl, C3_s cycloalkyl, C alkoxy, N(R10)R11, CN, NO, N02, F, CI, Br, I, CF3, (CH2)p-C(0)Yl, S(O)2R50, CH=C(H)R28, C=C-R24 ? benzyl, phenyl and naphthyl;
the ethine being unsubstituted or substituted by 1 substitutent selected from the group consisting of Ci-io alkyl, C3-s cycloalkyl, C alkoxy, N(R10)R11 , CN, NO, N02, F, CI, Br, I, CF3, (CH2)p-C(0)Yl, S(O)2R50, CH=C(H)R28, C≡C-R24 ? benzyl, phenyl and naphthyl; p is independently an integer from 0 to 10; any of the R24, R34, R28 and R38 are identical or different and independently from each other selected from the group consisting of H, Ci-io alkyl, C(R25)(R26)-0-R27; any of the R25, R26 and R27 are identical or different and independently from each other selected from the group consisting of H and G-io alkyl; any of the R50 and R 1 are identical or different and independently from each other selected from the group consisting of OH, Ci-6 alkyl and G-6 alkoxy; any of the Yl, Y2 and R13 are identical or different and independently selected from the group consisting of H, OH, C(R14)(R15)R16, Ci_6 alkyl, O-Ci-e alkyl, phenyl, benzyl, O-phenyl, O- Ci-6 alkylen-O-Ci-6 alkyl and N(R19)R20;
any of the R14, R15 and R16 are identical or different and independently from each other selected from the group consisting of H, F, CI and Br; any of the RIO, Rl 1, R17, R18, R19 and R20 are identical or different and are independently from each other H or Ci-e alkyl, or RIO and Rl 1, R17 and R18 or R19 and R20 represent together tetramethylene or pentamethylene.
DETAILED DESCRIPTION OF THE INVENTION
Preferably X is Br.
Preferably, when RINGA is a heterocyclic ring, then RINGA has 1 , 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N and S. Preferably, when RINGB is a heterocyclic ring, then RINGB contains 1, 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N and S.
Preferably, RINGA is an aromatic ring.
Preferably, RINGB is an aromatic ring.
More preferably, RINGA and RINGB are aromatic rings.
Preferably, COMPSUBST is selected from the group consisting of COMPSUBST-I,
Figure imgf000008_0001
polystyrene, ethene and ethine;
wherein COMPSUBST-I, ethene and the ethine are as defined herein, also with all their
embodiments.
In one embodiment, COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is
selected from the group consisting of
Figure imgf000008_0002
preferably, COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is selected from the group consisting of
Figure imgf000009_0001
more preferably, COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is selected from the group consisting of
Figure imgf000009_0002
even more preferably, COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is selected from the group consisting of
Figure imgf000009_0003
especially, COMPSUBST-I is RINGA and is selected from the group consisting of
Figure imgf000009_0004
more especially, COMPSUBST-I is RINGA and is selected from the group consisting of
Figure imgf000009_0005
and with RINGA or RINGA condensed with RINGB being unsubstituted or substituted by 1, 2, 3 or 4 in case of RINGA being a monocyclic compound with 5 endocyclic atoms, by 1, 2, 3, 4 or 5 in case of RINGA being a monocyclic compound with 6 endocyclic atoms, by 1, 2, 3, 4, 5 or 6 in case of RINGA condensed with RINGB being a bicyclic compound wherein a 5-membered and a 6-membered ring are ortho-fused,
by 1, 2, 3, 4, 5, 6 or 7 in case of RINGA condensed with RINGB being a bicyclic compound wherein two 6-membered rings are ortho-fused,
identical or different substituents independently from each other selected from the group consisting of CMO alkyl, C3-s cycloalkyl, Ci_4 alkoxy, OH, C(H)=0, N(R10)R11, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50, CH=C(H)R28, C^_ C-R24 s benzyl, phenyl and naphthyl;
said Ci-io alkyl substitutent is unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, OH, 0-C(0)-Ci-5 alkyl, O-Ci-io alkyl, S-Ci-10 alkyl, S(0)-Ci-io alkyl, S(02)-Ci-io alkyl, O-Ci-e alkylen-O-Ci-e alkyl, C3-8 cycloalkyl and 1,2,4-triazolyl;
said benzyl, phenyl and naphthyl substitutent is independently from each other unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, CM alkoxy, N02 and CN;
wherein
RIO and Rl 1 are identical or different and are independently from each other H or Ci-6 alkyl or RIO and Rl 1 represent together a tetramethylene or a pentamethylene group;
R24 and R28 are identical or different and are independently from each other OH, Ci-io alkyl, C(R25)(R26)-0-R27, with R25, R26 and R27 being identical or different and indepedently from each other being H or C 1-10 alkyl;
R50 is OH, Ci-6 alkyl or C 1-6 alkoxy;
Yl is H, OH, C (R14) (R15) R16, Ci-e alkyl, O-Ci 6, phenyl, benzyl, O-phenyl, O-G 6 alkylen-O- C1-6 alkyl or N (R19) R20 with R14, R15, R16 being identical or different and independently from each other H, F, CI or Br;
R19 and R20 being identical or different and are independently from each other H or Ci-6 alkyl or R19 and R20 represent together a tetramethylene or a pentramethylene group; and
m is independently an integer from 0 to 10.
Herein preferably at each occurence, m, n, p and q are identical or different and independently from each other an integer 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; more preferably at each occurence, m, n, p and q are identical or different and independently from each other an integer from 0 to 4 and in particular 0, 1, 2, 3 or 4;
even more preferably at each occurence, m, n, p and q are independently 0 or 4.
In a preferred embodiment at each occurence, Yl, Y2 and R13 are identical or different and
independently from each other selected from the group consisting of H, OH, C(R14)(R15)R16, C2-6 alkyl, O-G 6 alkyl, phenyl, benzyl, O-phenyl, O-Ci 6 alkylen-O-G-e alkyl and N(R19)R20; more preferably at each occurence, Yl, Y2 and R13 are identical or different and independently from each other selected from the group consisting of H, OH, C1-2 alkyl, and O-C1-2 alkyl.
More preferably, RINGA or RINGA condensed with RINGB is unsubstituted or substituted
by 1, 2 or 3 in case of RINGA being a monocyclic compound with 5 endocyclic atoms, by 1, 2, 3, 4 or 5 in case of RINGA being a monocyclic compound with 6 endocyclic atoms, by 1, 2, 3, 4 or 5 in case of RINGA consensed with RINGB being a bicyclic compound
wherein a 5-membered and a 6-membered ring are ortho-fused,
by 1, 2, 3 or 4 in case of RINGA condensed with RINGB being a bicyclic compound wherein two 6-membered rings are ortho-fused,
identical or different substituents independently from each other selected from the group
consisting of C alkyl, C alkoxy, OH, C(H)=0, N(R10)R11, CN, F, CI, Br, CF3, (CH2)m-C(0)Yl, and S(O)2R50;
said Ci-4 alkyl substitutent is unsubstituted or substituted with 1, 2 or 3 identical or different
substituents selected from the group consisting of halogen;
with R10, Rl 1, Yl and R50 as defined above, also with all their embodiments. embodiment, COMPSUBST is selected from the group consisting of benzene, pyrazole,
Figure imgf000011_0001
11
Figure imgf000012_0001

Figure imgf000013_0001
Figure imgf000014_0001
wherein
Rl is selected from the group consisting of Ci-io alkyl, C3-8 cycloalkyl, C1-4 alkoxy, OH, N(R10)R11, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50, CH=C(H)R28, C≡C-R24 ^ benzyl, phenyl and naphthyl;
Yl, RIO, Rl 1, m, R50, R28 and R24 are as defined herein, also with all their embodiments; preferably, Yl and Rl independently are Ci-6 alkyl or O- Ci-6 alkyl.
In a preferred embodiment, COMPSUBST is selected from the group consisting of
Figure imgf000014_0002
Figure imgf000015_0001
Rl is selected from the group consisting of G-io alkyl, C3-8 cycloalkyl, C1-4 alkoxy, OH, N(R10)R11, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50, CH=C(H)R28, C=C-R24 ? benzyl, phenyl and naphthyl;
Yl, RIO, Rl 1, m, R50, R28 and R24 are as defined herein, also with all their embodiments; preferably, Yl and Rl independently are Ci-6 alkyl or O-Ci-6 alkyl.
In a more preferred embodiment, COMPSUBST is selected from the group consisting of
Figure imgf000016_0001
wherein
Yl is as defined herein, also with all their embodiments; preferably, Yl is d_6 alkyl or O-Ci 6 alkyl;
more preferably, Yl is methyl, ethyl, methoxy
even more preferably ethyl or ethoxy.
In an even more preferred embodiment, COMPSUBST is selected from the group consisting of
Figure imgf000017_0001
In an especially preferred embodiment, COMPSUBST is selected from the rou consistin of
Figure imgf000017_0002
and
Figure imgf000018_0001
In a more especially preferred embodiment, COMPSUBST is selected from the group consisting of
Figure imgf000018_0002
In a further preferred embodiment COMPSUBST is a compound of formula (II), or a compound of formula (IV), wherein als residues are defined as above, also with all their embodiments.
In a further preferred embodiment COMPSUBST is
an ethene which is unsubstituted or substituted by 1 or 2 substitutents selected from the group
consisting of Ci-io alkyl, C3-e cycloalkyl, C alkoxy, N(R10)R1 1, CN, F, CI, Br, I, CF3,
(CH2)m-C(0)Yl, S(O)2R50, benzyl, phenyl and naphthyl; or
an ethine which is unsubstituted or substituted by 1 substitutent selected from the group consisting of CLIO alkyl, C3_6 cycloalkyl, C alkoxy, N(R10)R11, CN, F, CI, Br, I, CF3, (CH2)m-C(0)Yl,
S(O)2R50, benzyl, phenyl and naphthyl;
more preferably, the ethene is unsubstituted or substituted by 1 or 2 substitutents selected from the group consisting of CMO alkyl, CM alkoxy, N(R10)R11, CN, F, CI, Br, I, CF3, (CH2)m-
C(0)Y1, benzyl and phenyl;
more preferably, the ethine being unsubstituted or substituted by 1 substitutent selected from the group consisting of CMO alkyl, CM alkoxy, N(R10)R11, CN, F, CI, Br, I, CF3, (CH2)m-
C(0)Y1, benzyl and phenyl;
with RIO, Rl 1 , m, Yl and R50 as defined above, also with all their embodiments.
Embodiments of the substituted ethene are propene, ethene- 1,1-diyldibenzene and 3,3-dimethylbut- 1-ene.
An embodiment of the substituted ethine is 1-octyne. In a further preferred embodiment COMPSUBST is selected from a compound of formula (V) or a compound of formula (VI)
Figure imgf000019_0001
(V) (VI) wherein
R43 is H or CH3;
R44 is selected from the group consisting of Ci-io alkyl, C alkoxy, OH, N(R10)R11, CN, NO,
N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50;
with RIO, Rl 1, m, Yl and R50 as defined above, also with all their embodiments.
Preferably, ALKHAL is a compound of formula (III);
R3-X (III) wherein
X is Br or I; preferably X is Br;
R3 is Ci-20 alkyl or a Ci-20 alkyl wherein in the alkyl chain at least one hydrogen is substituted by F or CI, preferably by F;
more preferably,
R3 is Ci-15 alkyl or Ci-15 alkyl wherein in the alkyl chain at least one hydrogen is substituted by F or CI, preferably by F;
even more preferably,
R3 is Ci-10 alkyl or Ci-10 alkyl wherein in the alkyl chain at least one hydrogen is substituted by F or CI, preferably by F.
Especially, R3 is Ci-20 alkyl, more especially Ci-15 alkyl, even more especially Ci-10 alkyl, wherein all hydrogen atoms are independently substituted by CI or F,
preferably wherein all hydrogen atoms are substituted by F, i.e. an perfluoro alkyl;
in particular, the alkyl is a linear perfluoro alkyl.
Preferably, X is Br or I;
in one embodiment X is I;
in a preferred embodiment, X is Br;
also with R3 in all its embodiments.
In a preferred embodiment, ALKHAL is a perfluoroalkyl halide, F2HC-CI or F2HC-Br, preferably
ALKHAL is a perfluoroalkyl bromide or iodide, F2HC-CI or F2HC-Br;
preferably
X is Br or I; and
R3 is perfluoro Ci-20 alkyl, or
ALKHAL is F2HC-C1 or F2HC-Br;
even more preferably,
X is Br or I; and
R3 is perfluoro Ci-15 alkyl, or
ALKHAL is F2HC-C1 or F2HC-Br;
especially,
X is Br or I; and
R3 is perfluoro Ci-10 alkyl, or
ALKHAL is F2HC-CI or F2HC-Br.
In particular, ALKHAL is selected from the group consisting of F21G0-I, FnCs-I, F13C6-I, F9C4-I, F3C-I, F2iCio-Br, FnCg-Br, Fi3C6-Br, F9C4-Br, F3C-Br, F3C-CI, F2HC-CI, and F2HC-Br; more in particular, ALKHAL is selected from the group consisting of n-F2iGo-I, n-FnCs-I, n- Fi3C6-I, n-F9C4-I, F3C-I, n-F2iCio-Br, n-FnC8-Br, n-Fi3C6-Br, n-F9C4-Br, F3C-Br, F3C-CI,
Figure imgf000020_0001
In a further preferred embodiment, ALKHAL is selected from the group consisting of F21C10-I,
FnCs-I, FnCe-I, F9C4-I, F3C-I, F3C-Br, and F2HC-Br;
in particular, ALKHAL is selected from the group consisting of n-F2iGo-I, n-FnCs-I, n-Fi3C6-I, n-
F9C4-I, F3C-I, F3C-Br, and F2HC-Br.
In a further preferred embodiment, ALKHAL is selected from the group consisting of F2iGo-Br,
FnCs-Br, FnCs-Br, F9C4-Br, F3C-Br, and F2HC-Br;
in particular from the group consisting of n-F2iCio-Br, n-FnCs-Br, n-FnCe-Br, n-F9C4-Br, F3C-Br, and F2HC-Br. The reaction is performed in the presence of or using a catalyst CAT, CAT is Co-Ll/C, which is cobalt 1 ,10-phenanthroline supported on carbon,
preferably, CAT is cobalt 1 ,10-phenanthroline supported on graphene.
Co-Ll/C can be prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al, Nature Chemistry, 2013, 5, 537-543, especially as described schematically in Figure 1 therein, that is by reacting Co(OAc)2 . 4 H20 with 1 , 10-phenantroline and thereby forming a complex Co (phen)2(OAc)2 which is then absorbed on carbon black and kept e.g. at 800 °C for 2 h under argon to provide Co-Ll/C, which contains cobalt oxide supported on 1,10- phenantroline/carbon black.
Preferably, the amount of Co in CAT is from 0.1 to 20 %, more preferably from 0.5 to 15 %, even more preferably from 1 to 12.5 %, especially from 2 to 12.5 %, the % are % by weight and are based on the total weight of CAT.
Preferably, the amount of Co in the reaction is from 0.001 to 20 %, more preferably from 0.01 to 15 %, even more preferably from 0.025 to 12.5%, especially from 0.05 to 10%, the % are % by weight % and are based on the weight of ALKHAL.
Preferably, from 1 to 20 mol equivalents, more preferably 1 to 15 mol equivalents, even more preferably from 1 to 10 mol equivalents, of COMPSUBST are used in the reaction, the mol equivalents are based on the molar amount of ALKHAL.
The reaction temperature of the reaction is preferably from 20 to 200°C, more preferably from 20 to 150°C, even more preferably from 40 to 150°C, especially from 70 to 150°C, more especially from 70 to 140°C, even more especially from 100 to 140°C.
The reaction time of the reaction is preferably from 30 min to 72 h, more preferably from 6 h to 60 h, even more preferably from 10 h to 55 h.
Preferably, the reaction is done in the presence of a base BAS, BAS is selected from the group consisting of Cs2C03, CsHCOs, K2CO3, K3PO4, K2HPO4, KOAc, KOH, Mg(OH)2, TEA, DBU, and HNEt2.
More preferably, BAS is selected from the group consisting of CS2CO3, K2CO3, K3PO4, K2HPO4, KOAc, KOH, Mg(OH)2, TEA, DBU, and HNEt2.
Even more preferably, BAS is CS2CO3 or K2CO3;
especially, BAS is CS2CO3. Preferably, the amount of BAS in the reaction is from 0.1 to 10 mol equivalents, more preferably 0.5 to 5 mol equivalents, even more preferably from 0.75 to 2.5 mol equivalents, the mol equivalents are based on the molar amount of ALKHAL.
Preferably, the reaction is done under inert atmosphere. Preferably, the inert atmosphere is achieved by the use of an inert gas preferably selected from the group consisting of argon, another noble gas, lower boiling alkane, nitrogen and mixtures thereof.
The lower boiling alkane is preferably a C1-3 alkane, i.e. methane, ethane or propane.
The reaction can be done in a closed system, or it can be done at a pressure caused by the chosen temperature in a closed system. It is also possible to apply pressure with said inert gas. It is also possible to carry out the reaction at ambient pressure. When ALKHAL is a gaseous substance, e.g. in case of CF3Br, ALKHAL can be used for applying the desired pressure, e.g. when charging ALKHAL.
When pressure is applied, then preferably the reaction is done at a pressure of from 1 to 1000 bar, more preferably of from 1 to 500 bar, even more preferably of from 1 to 200 bar, especially of from 1 to 100 bar, more especially of from 1 to 50 bar.
When ALKHAL is a gaseous substance, e.g. in case of CF3Br, then pressure is applied, then preferably the reaction is done at a pressure of from 2 to 1000 bar, more preferably of from 2 to 500 bar, even more preferably of from 2 to 200 bar, especially of from 2 to 100 bar, more especially of from 2 to 50 bar.
The vapour pressure of CF3Br at ambient temperature is around 14 bar, so when CF3Br is used as ALKHAL, then preferably the reaction is done initially at a pressure of 14 bar or higher.
The reaction can be done by using a solvent SOL. SOL is preferably selected from the group consisting of alkanes, chlorinated alkanes, ketones, ethers, esters, aliphatic nitrils, aliphatic amides, sulfoxides, and mixtures thereof.
More preferably SOL is selected from the group consisting of C5-8 alkane, C5-C10 cycloalkane, chlorinated Ci-s alkane, acetone, methylethylketone (MEK), diethylketone, methyl tert-butyl ether (MTBE), tetrahydrofuran (THF), methyltetrahydrofuran, ethylacetate, butylacetate, valeronitril, acetonitrile, dimethylformamide (DMF), dimethylacetamide, N-methylpyrrolidone (NMP), dimethylsulfoxide (DMSO), dioxaneisopropanol, and mixtures thereof.
Even more preferably, SOL is selected from the group consitsing of acetone, MEK, heptane, cyclohexane, DMSO, dichloromethane, ethylacetate, dimethylacetamide, DMF, dioxane, THF, isopropanol, NMP, and mixtures thereof. Especially, SOL is acetone or methylethylketone;
more especially, SOL is acetone.
It is also possible to use COMPSUBST simultaneously as substrate and as solvent.
As an alternative, the reaction can also be carried out in the absence of a solvent, i.e. "in substance". In this case, preferably COMPSUBST serves as solvent. This procedure is in particular applicable for compounds COMPSUBST being liquid at room temperature or having a low melting point of less than 40 °C.
The amount of SOL is preferably from 0.1 to 100 fold, more preferably from 1 to 50 fold, even more preferably from 1 to 25 fold, especially from 1 to 15 fold of the weight of ALKHAL.
After the reaction, ALKYLCOMPSUBST can be isolated by standard methods such as evaporation of volatile components, extraction, washing, drying, concentration, crystallization, chromatography and any combination thereof, which are known per se to the person skilled in the art.
COMPSUBST, CAT, ALKHAL and BAS are commercially available and can be prepared according to known precedures.
In one embodiment, the reaction is done in the presence of a compound COMPSALT;
COMPSALT is selected from the group consisting of Nal, KJ, Csl, NaBr, KBr, CsBr,
N(R30)(R31)(R32)(R33)I, and (R30)(R31)(R32)(R33)Br;
R30, R31, R32 and R33 are identical or different and independently from each other selected from the group consisting of H and Ci-io alkyl;
preferably, R30, R31, R32 and R33 are identical or different and independently from each other selected from the group consisting of H and C2-6 alkyl;
more preferably, COMPSALT is selected from the group consisting of Nal, (n-Bu)4NI, NaBr, and
(n-Bu)4NBr.
The reaction is preferably done in the presence of a compound COMPSALT and X is Br.
EXAMPLES
Yield:
Yield as used herein is given as a molar yield of the product ALKYLCOMPSUBST based on molar amount of ALKHAL and was determined by quantitative GC analysis with hexadecane as internal standard or as NMR yield, if not otherwise stated. In particular, yield = conversion x selectivity.
Conversion:
Conversion as used herein is calculated from the molar amount of the remaining ALKHAL( e.g. determining quantitative GC analysis with hexadecane as internal standard), in particular conversion denote the amount of ALKHAL which has reacted during the reaction.
Selectivity:
Selectivity denotes the molar amount of the desired product ALKYLCOMPSUBST based on reacted starting material.
Ratio of Isomers and position of alkylation:
This ratio was determined by NMR spectroscopy. Selectivity as given herein always refers to the total amount of all isomers and alkylation positions of ALKYLCOMPSUBST, if not otherwise stated.
Preparation of CAT:
Co-Ll/C and its preparation is described in Westerhaus et al., Nature Chemistry, 2013, 5, 537-543, especially in Figure 1 therein, and in the supplementary information to this article, available under DOI: 10.1038 NCHEM.1645, under chapter "SI. Catalyst preparation", which is cited here:
SI. Catalyst preparation Cobalt(II) acetate tetrahydrate (Sigma-Aldrich >98%, 126.8 mg, 0.5 mmol) and 1 , 10-phenanthroline (Sigma-Aldrich, >99%, 183.5 mg, 1.0 mmol)
(Co:phenanthroline = 1 :2 molar ratio) were stirred in ethanol (50 mL) for approximately 30 minutes at room temperature. Then, carbon powder (689.7 mg) (VULCAN® XC72R, Cabot Corporation Prod. Code XVC72R; CAS No. 1333-86-4) was added and the whole reaction mixture was refluxed for 4 hours. The reaction mixture was cooled to room temperature and the ethanol was removed in vacuo. The solid sample obtained was dried at 60 °C for 12 hours, after which it was grinded to a fine powder. Then, the grinded powder was transferred into a ceramic crucible and placed in the oven. The oven was evacuated to ca. 5 mbar and then flushed with argon. The oven was heated to 800 °C at the rate of 25 °C per minute, and held at 800 °C for 2 hours under argon atmosphere. After heating was switched off and the oven cooled back to room temperature. During the whole process argon was constantly passed through the oven . Elemental analysis of Co-Phenanthroline/C (wt%): C = 92.28, H = 0.20, N = 2.70, Co = 3.05, 0 = 1.32
As Westerhaus et al., Nature Chemistry, 2013, 5, 537-543, discloses on page 540, in the active catalyst system Co304 Ll/C the particle sizes had a wide size distribution with a fraction of particles of 2 to 10 nm, and particles and agglomerates in the range 20 to 80 nm. Occasionally, even larger structures up to 800 nm were present. The ratio between all cobalt atoms and all nitrogen atoms in the near-surface region was 1 :4.7.
Protocoll 1: General Procedure 1 "in substance"
A mixture of the substrate COMPSUBST (20 eq, 40 mmol), ALKHAL (1 eq, 2 mmol), Co-Ll/C (preferably 10 mol% Co, 400 mg, 3 wt% Co-Ll/C, if not otherwise stated, prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al, Nature
Chemistry, 2013, 5, 537-543) and BAS, preferably CS2CO3 (1 eq, 2 mmol, 652 mg), was placed in a thick-walled pyrex tube with a magnetic stirring bar. The gas atmosphere in the pyrex tube was flushed with nitrogen, the tube was closed with a screw cap and heated with stirring for the reaction time as stated, preferably for 24 h, at the reaction temperature as stated, preferably at 130°C. The resulting mixture was cooled to room temperature and diluted with dichloromethane, ether or methanol (10 ml). The solids were removed by centrifugation (3000 rpm, 15 min) or by filtration. The obtained product solution was analyzed by quantitative GC analysis (internal standard hexadecane) or 19F-NM analysis using the internal standards 1 ,2-difluorobenzene or 1,4- difluorobenzene.
Isolation of the products was conducted by pipette column chromatography using FluoroFlash® reverse phase silica gel (Sigma Aldrich No. 00866) and a gradient solvent elution (1. MeOH : H2O (4: 1 v/v, 10 mL) 2. MeOH (100%, 10 mL) 3. acetone (100%, 10 mL) for long chains fluoroalkyl chains (alkyl chain containing 10 or more carbon atoms) or by normal phase silical gel
chromatography using silicagel (Sigma Aldrich No. 236802) and a gradient solvent elution (1. n- pentane (100%) 2. pentane : diethylether (1 : 1 v/v, 10 ml) for fluoroalkyl chains containing less than 10 carbon atoms.
Protocoll 2: General Procedure 2 "in solution"
A mixture of the substrate COMPSUBST (2 eq, 4 mmol), solvent SOL (2 ml), ALKHAL (1 eq, 2 mmol), Co-Ll/C (10 mol% Co, 400 mg, 3 wt% Co/C, prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al., Nature Chemistry, 2013, 5, 537-543) and CS2CO3 (2 eq, 4 mmol, 1.3 g) was placed in a thick-walled pyrex tube with a magnetic stirring bar. The gas atmosphere in the pyrex tube was flushed with nitrogen, the tube was closed with a screw cap and heated with stirring for the reaction time as stated, preferably for 24 h, at the reaction temperature as stated, preferably at 130°C. The resulting mixture was cooled to room temperature and diluted with dichloromethane, ether or methanol (10ml). The solids were removed by centrifugation (3000 rpm, 15 min) or by filtration. The obtained product solution was analyzed by quantitative GC analysis (internal standard hexadecane) or 19F-NMR analysis using the internal standards 1 ,2-difiuorobenzene or 1,4-difluorobenzene.
Isolation of the products was conducted by pipette column chromatography using FluoroFlash® reverse phase silica gel (Sigma Aldrich No. 00866) and a gradient solvent elution (1. MeOH : H20 (4: 1 v/v, 10 mL) 2. MeOH (100%, 10 mL) 3. acetone (100%, 10 mL) for long chains fluoroalkyl chains (alkyl chain containing 10 or more carbon atoms) or by normal phase silical gel
chromatography using silicagel (Sigma Aldrich No. 236802) and a gradient solvent elution (1. pentane (100%) 2. pentane : diethylether (1 : 1 v/v, 10 ml) for fluoroalkyl chains containing less than 10 carbon atoms.
Protocoll 3: General Procedure 3 "in substance" with ALKHAL which is gaseous at ambient temparture
A mixture of the substrate COMPSUBST (1 eq, 2.5 mmol), Co-Ll/C (10 mol%, 0.25 mmol, 0.49 g, 3 wt% Co/C, prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al., Nature Chemistry, 2013, 5, 537-543), and Cs2C03 (1.1 eq, 2.5 mmol, 0.894 g) was placed in a magnetically stirred Parr autoclave (Parr Instruments 4560 series). After replacing the air in the autoclave with nitrogen, ALKHAL gas was used to increase the pressure in the autoclave to 15 bars, the autoclave was sealed and heated at 130°C for 48 h with stirring. After cooling the reaction mixture to room temperature, the pressure was released from the autoclave, the reaction mixture diluted with 25 ml diethylether and 1 ,2-difluorobenzene (300 mg) was added as an internal standard. The solids were removed by centrifugation (3000 rpm, 15 min) or filtration. An aliquot was taken for quantitative GC-MS and 19F-NMR analysis. The filtrate was concentrated under reduced pressure and the product isolated by column chromatography and gradient elution (1. pentane (100%, 10ml) 2. pentane : diethylether (1 : 1 v/v, 10 ml)) to give the product
ALKYLCOMPSUBST.
Protocoll 4: General Procedure 4 "in solution" with ALKHAL which is gaseous at ambient temparture
A mixture of the substrate COMPSUBST (1 eq, 2.5 mmol), Co-Ll/C (10 mol%, 0.25 mmol, 0.49 g, 3 wt% Co/C, prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al., Nature Chemistry, 2013, 5, 537-543), and Cs2C03 (1.1 eq, 2.5 mmol, 0.894 g) and 5 ml acetone (dried, Sigma Aldrich No. 1.00299) was placed in a magnetically stirred Pan- autoclave (Parr Instruments 4560 series). After replacing the air in the autoclave with nitrogen, ALKHAL gas was used to increase the pressure in the autoclave to 15 bars, the autoclave was sealed and heated at 130°C for 48 h with stirring. After cooling the reaction mixture to room temperature, the pressure was released from the autoclave, the reaction mixture diluted with 25 ml diethylether and 1 ,2-difluorobenzene (300 mg) was added as an internal standard. The solids were removed by centrifugation (3000 rpm, 15 min) or filtration. An aliquot was taken for quantitative GC-MS and 19F-NMR analysis. The filtrate was concentrated under reduced pressure and the product isolated by column chromatography and gradient elution (1. pentane (100%, 10ml) 2. pentane : diethylether (1 : 1 v/v, 10 ml)) to give the product ALKYLCOMPSUBST.
Example 1: 1,3,5-trimethoxybenzene
A mixture of the 1,3,5- trimethoxybenzene (1 eq, 2.5 mmol, 0.420 g), Co-Ll/C (10 mol%, 0.25 mmol, 0.49 g, 3 wt% Co/C, prepared according to SI. Catalyst preparation in the Supplementary Information of Westerhaus et al., Nature Chemistry, 2013, 5, 537-543), and CS2CO3 (1.1 eq, 2.5 mmol, 0.894 g) and 5 ml acetone (dried, Sigma Aldrich No. 1.00299) was placed in a magnetically stirred Parr autoclave (Parr Instruments 4560 series). After replacing the air in the autoclave with nitrogen, CFsBr gas was used to increase the pressure in the autoclave to 15 bars, the autoclave was sealed and heated at 130°C for 48 h with stirring. After cooling the reaction mixture to room temperature, the pressure was released from the autoclave, the reaction mixture diluted with 25 ml diethylether and 1 ,2-difluorobenzene (300 mg) was added as an internal standard. The solids were removed by centrifugation (3000 rpm, 15 min) or filtration. An aliquot was taken for quantitative GC-MS and 19F-NMR analysis. The filtrate was concentrated under reduced pressure and the product isolated by column chromatography and gradient elution (1. pentane (100%, 10ml) 2. pentane : diethylether (1 : 1 v/v, 10 ml)) to give l,3,5-trimethoxy-2-(trifiuoromethyl)benzene (1.5 mmol, 343 mg, 58% yield) and l,3,5-trimethoxy-2,4-bis(trifluoromethyl)benzene (1.1 mmol, 338 mg, 42% yield) based on the substrate 1,3,5-trimethoxybenzene. The identity of the products was confirmed using HRMS EI (m z): [M]+ calcd for ClOHl 1F303: 236.06603; found: 236.06621 and for C11H10F6O3: 304.05341; found: 304.05351.
Example 2
Figure imgf000027_0001
Conversion, selectivity and yield are based on the consumption of the respective limiting reagent. In the case of the protocol 1 (neat) the starting material is solvent as well, hence the fluoroalkyl reagent is limiting and the yields are based on it.
In Table 1 and Table 2 the following abbreviations are used:
ac aceton
CONV conversion
PROT protocoll
SEL selectivity SOL solvent
T reaction temperature
t reaction time
ALKHAL has a linear chain, if not otherwise stated.
Figure imgf000028_0001
Figure imgf000029_0001
Table 2
Entry SOL T t CONV SEL yield
1 ac 130 16 92% 90% 82.5%
2 ac 130 48 100% 58% 58%
3 ac 130 48 100% 42% 42%
4 — 130 40 21% 88% 18.5%
5 — 130 40 15% 30% 4.5%
6 — 130 20 100%]) 46% 46%
7 — 120 20 100%]) 60% 60%
8 — 130 20 93%1} 46% 43%
9 — 130 20 100%]) 97% 97% 10 — 130 20 69%1} 23% 16%
11 — 130 20 89%1} 27% 24%
12 — 130 20 87%1} 34% 30%
13 — 130 20 100%]) 39% 39%
14 — 130 20 100%]) 74% 74%
15 — 130 20 100%]) 55% 55%
Example 3
# gives the entry no.
CS means COMPSUBST.
AH means ALKHAL.
ACS means ALKYLCOMPSUBST.
YD means Yield.
IS means isomer(s).
REM means Remarks; were observations are given and where the analytical methods are stated which were used for determination of structure and yield. GC-MS means gas chromatography combined with mass sepctrometry. NM was 19F-NMR
The reactions in Table 3 were done according to Protocoll 1.
Reactuion time was 16 h, except for entry 6, where the reaction time was 20 h.
BAS was Cs2C03.
CAT was 5 wt% Co-Ll/C.
Any alkyl chain is a linear alkyl chain, if not otherwise stated.
Yield was combined yield of any product or isomer observed.
Figure imgf000030_0001
Figure imgf000031_0001
3 IS unsat¬
Figure imgf000032_0001
urated with 50% yield, additional saturated products with 17% yield GCMS NMR
4 IS
GCMS NMR
1 IS
GCMS
NMR
2 IS
GCMS
NMR
Figure imgf000033_0001
Figure imgf000034_0001

Claims

1. Method for the preparation of an alkylated, fluoro alkylated, chloro alkylated or
fluorochloro alkylated compound ALKYLCOMPSUBST with heterogeneous catalysis by a reaction of a compound COMPSUBST with an alkylating agent ALKHAL in the presence of a catalyst CAT;
ALKHAL is a compound of formula (III);
R3-X (III) wherein
X is Br or I;
R3 is Ci-20 alkyl;
wherein the Ci-20 alkyl residue R3 of ALKHAL is either unsubstituted, or at least one hydrogen residue of the Ci-20 alkyl residue R3 of ALKHAL is substituted by F or CI;
CAT is Co-Ll/C;
LI is 1,10-phenanthroline;
COMPSUBST is selected from the group consisting of a compound COMPSUBST-I, compound of formula (II), compound of formula (IV), polystyrene, ethene and ethine; wherein
COMPSUBST-I is a ring RINGA or is a RINGA condensed with a ring RINGB;
RINGA is a 5 or 6 membered carbocyclic or heterocyclic ring,
when RINGA is a heterocyclic ring, then RINGA has 1 , 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N, O and S;
when RINGA is a 5 membered ring, then RINGA is unsubstituted or substituted by 1 , 2, 3 or 4 identical or different subsitutents,
when RINGA is a 6 membered ring then RINGA is unsubstituted or substituted by 1, 2, 3, 4 or
5 identical or different subsitutents,
any of said subsitutents of RINGA is independently from any other of said substitutent of
RINGA selected from the group consisting of Ci-10 alkyl, C3-8 cycloalkyl, C1-4 alkoxy,
OH, N(R10)R11, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50,
CH=C(H)R28, C≡C-R24 1 benzyl, phenyl and naphthyl; RINGB is a 5 or 6 membered carbocyclic or heterocyclic ring, resulting in a bicyclic having 8,
9 or 10 ring members in total,
when RINGB is a heterocyclic ring, then RINGB contains 1 , 2 or 3 identical or different
endocyclic heteroatoms independently from each other selected from the group consisting of N, O and S;
RINGB is unsubstituted or substituted with 1 , 2 or 3 identical or different substituents in case of RINGB being a 5 membered ring, with 1, 2, 3 or 4 identical or different substituents in case of RINGB being a 6 membered ring, which identical or different substitutents are independently from each other selected from the group consisting of Ci-io alkyl, C3-8 cycloalkyl, CM alkoxy, OH, N(R17)R18, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)„-C(0)Y2, S(0)2R51, CH=C(H)R38, C=C-R34 s benzyl, phenyl and naphthyl; any of said Ci-10 alkyl substitutent of RINGA or RINGB is unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, OH, 0-C(0)-Ci_5 alkyl, O-Ci-io alkyl, S-G-io alkyl, S(0)-Ci-io alkyl, S(02)-Ci_io alkyl, O-Ci-6 alkylen-O-G-6 alkyl, C3-8 cycloalkyl and 1,2,4-triazolyl;
any of said benzyl, phenyl and naphthyl substitutent of RINGA or RINGB is independently from each other unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, C alkoxy, NO2 and CN; m and n are identical or different and independently from each other an integer from 0 to 10; wherein
the compound of formula (II) and the compound of formula (IV) being
Figure imgf000036_0001
(II) (IV)
R40 and R41 are identical or different and independently from each other selected from the group consisting of -(CH2)q-C(0)R13 and -CN;
R42 is selected from the group consisting of -(CH2)q-C(0)R13, -CN and R13;
q is independently an integer from 0 to 10; wherein
the ethene being unsubstituted or substituted by 1, 2 or 3 substitutents selected from the group
consisting of G-io alkyl, C3-8 cycloalkyl, C alkoxy, N(R10)R11, CN, NO, N02, F, CI, Br, I, CF3, (CH2)p-C(0)Yl , S(O)2R50, CH=C(H)R28, C=C-R24 ? benzyl, phenyl and naphthyl;
the ethine being unsubstituted or substituted by 1 substitutent selected from the group consisting of Ci-io alkyl, C3-s cycloalkyl, C alkoxy, N(R10)R1 1 , CN, NO, N02, F, CI, Br, I, CF3, (CH2)p-C(0)Yl , S(O)2R50, CH=C(H)R28, C≡C-R24 ? benzyl, phenyl and naphthyl; p is independently an integer from 0 to 10; any of the R24, R34, R28 and R38 are identical or different and independently from each other selected from the group consisting of H, Ci-io alkyl, C(R25)(R26)-0-R27; any of the R25, R26 and R27 are identical or different and independently from each other selected from the group consisting of H and G-io alkyl; any of the R50 and R 1 are identical or different and independently from each other selected from the group consisting of OH, Ci-6 alkyl and Ci-6 alkoxy; any of the Yl , Y2 and R13 are identical or different and independently selected from the group consisting of H, OH, C(R14)(R15)R16, C1 -6 alkyl, O-Ci-e alkyl, phenyl, benzyl, O-phenyl, O- Ci-6 alkylen-O-Ci-6 alkyl and (R19)R20;
any of the R14, R15 and R16 are identical or different and independently from each other selected from the group consisting of H, F, CI and Br; any of the RIO, Rl 1, R17, R18, R19 and R20 are identical or different and are independently from each other H or Ci-6 alkyl, or RIO and Rl 1 , R17 and R18 or R19 and R20 represent together tetramethylene or pentamethylene.
2. Method according to claim 1 , wherein
when RINGA is a heterocyclic ring, then RINGA has 1 , 2 or 3 identical or different endocyclic heteroatoms independently from each other selected from the group consisting of N and S.
3. Method according to claim 1 or 2, wherein
RINGA is an aromatic ring.
4. Method according to one or more of claims 1 to 3, wherein COMPSUBST is selected from the group consisting of COMPSUBST-I,
Figure imgf000038_0001
polystyrene, ethene and ethine;
wherein COMPSUBST-I, ethene and the ethine are as defined in claim 1.
5. Method according to one or more of claims 1 to 4, wherein
COMPSUBST-I is RINGA or is RINGA condensed with RINGB and is selected from the group consisting of
Figure imgf000038_0002
with RINGA or RINGA condensed with RINGB being unsubstituted or substituted
by 1, 2, 3 or 4 in case of RINGA being a monocyclic compound with 5 endocyclic atoms, by 1, 2, 3, 4 or 5 in case of RINGA being a monocyclic compound with 6 endocyclic atoms, by 1, 2, 3, 4, 5 or 6 in case of RINGA condensed with RINGB being a bicyclic compound wherein a 5-membered and a 6-membered ring are ortho-fused,
by 1, 2, 3, 4, 5, 6 or 7 in case of RINGA condensed with RINGB being a bicyclic compound wherein two 6-membered rings are ortho-fused,
identical or different substituents independently from each other selected from the group consisting of G-io alkyl, C3-s cycloalkyl, C alkoxy, OH, C(H)=0, N(R10)R11, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50, CH=C(H)R28, C^__zC-R24 s benzyl, phenyl and naphthyl;
said Cl io alkyl substitutent is unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, OH, 0-C(0)-Ci-5 alkyl, O-Ci-io alkyl, S-Ci-io alkyl, S(0)-Ci-io alkyl, S(02)-Ci-io alkyl, 0-G-e alkylen-O-Ci-e alkyl, C3-8 cycloalkyl and 1,2,4-triazolyl; said benzyl, phenyl and naphthyl substitutent is independently from each other unsubstituted or substituted with 1, 2, 3, 4 or 5 identical or different substituents selected from the group consisting of halogen, CM alkoxy, N02 and CN;
wherein
RIO and Rl 1 are identical or different and are independently from each other H or Ci-e alkyl or RI O and Rl 1 represent together a tetramethylene or a pentamethylene group;
R24 and R28 are identical or different and are independently from each other OH, C1-10 alkyl, C(R25)(R26)-0-R27, with R25, R26 and R27 being identical or different and indepedently from each other being H or C 1-10 alkyl;
R50 is OH, Ci-6 alkyl or Ci-6 alkoxy;
Yl is H, OH, C (R14) (R15) R16, Ci-e alkyl, 0-G-6, phenyl, benzyl, O-phenyl, O-Ci-e alkylen-O- C1-6 alkyl or N (R19) R20 with R14, R15, R16 being identical or different and independently from each other H, F, CI or Br;
R19 and R20 being identical or different and are independently from each other H or Ci-6 alkyl or R19 and R20 represent together a tetramethylene or a pentramethylene group; and
m is independently an integer from 0 to 10.
6. Method according to one or more of claims 1 to 5, wherein
m, n, p and q are identical or different and independently from each other 0, 1 , 2, 3 or 4.
7. Method according to one or more of claims 1 to 6, wherein
Yl , Y2 and R13 are identical or different and independently from each other selected from the group consisting of H, OH, C(R14)(R15)R16, C2-6 alkyl, 0-G-e alkyl, phenyl, benzyl, O- phenyl, 0-G_6 alkylen-O-G-e alkyl and (R19)R20.
8. Method according to one or more of claims 1 to 7, wherein
RINGA or RINGA condensed with RINGB is unsubstituted or substituted
by 1, 2 or 3 in case of RINGA being a monocyclic compound with 5 endocyclic atoms, by 1, 2, 3, 4 or 5 in case of RINGA being a monocyclic compound with 6 endocyclic atoms, by 1, 2, 3, 4 or 5 in case of RINGA consensed with RINGB being a bicyclic compound
wherein a 5-membered and a 6-membered ring are ortho-fused,
by 1, 2, 3 or 4 in case of RINGA condensed with RINGB being a bicyclic compound wherein two 6-membered rings are ortho-fused,
identical or different substituents independently from each other selected from the group consisting of CM alkyl, C alkoxy, OH, C(H)=0, N(R10)R1 1 , CN, F, CI, Br, CF3, (CH2)m-C(0)Yl, and S(O)2R50; said CM alkyl substitutent is unsubstituted or substituted with 1, 2 or 3 identical or different substituents selected from the group consisting of halogen;
with RIO, Rl 1, Yl and R50 as defined in claim 1.
9. Method according to one or more of claims 1 to 8, wherein
Figure imgf000040_0001
40
Figure imgf000041_0001
Figure imgf000042_0001
Ġ wherein Rl is selected from the group consisting of G-io alkyl, C3-8 cycloalkyl, C1-4 alkoxy, OH,
N(R10)R11, CN, NH-OH, NO, N02, F, CI, Br, I, CF3, (CH2)m-C(0)Yl, S(O)2R50,
CH=C(H)R28, C≡C-R24 ? benzyl, phenyl and naphthyl;
Yl, RIO, Rl 1, m, R50, R28 and R24 are as defined in claim 1.
10. Method according to one or more of claims 1 to 9, wherein
R3 is Ci-20 alkyl, wherein all hydrogen atoms are independently substituted by CI or F.
11. Method according to one or more of claims 1 to 10, wherein
R3 is Ci-20 alkyl, wherein all hydrogen atoms are substituted by F.
12. Method according to one or more of claims 1 to 11, wherein
ALKHAL is selected from the group consisting of F21C10-I, FnCs-I, F13C6-I, F9C4-I, F3C-I, F21C10- Br, FnCs-Br, Fi3C6-Br, F9C4-Br, F3C-Br, F3C-CI, F2HC-CI, and F2HC-Br.
13. Method according to one or more of claims 1 to 12, wherein
Co-Ll/C is prepared by reacting Co(OAc)2 . 4 H20 with 1,10-phenantroline and thereby forming a complex Co (phen)2(OAc)2 which is then absorbed on carbon black and kept at 800 °C for 2 h under argon to provide Co-Ll/C.
PCT/EP2018/070242 2017-07-28 2018-07-26 Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis WO2019020726A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN201880049832.9A CN110944965A (en) 2017-07-28 2018-07-26 Method for the heterogeneously cobalt-catalyzed production of alkylated or fluoroalkylated, chloroalkylated, and fluorochloroalkylated compounds
JP2020504193A JP7219752B2 (en) 2017-07-28 2018-07-26 Process for the preparation of heterogeneous cobalt catalyzed alkylation or fluoro, chloro and fluorochloro alkylated compounds
US16/632,572 US10968187B2 (en) 2017-07-28 2018-07-26 Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis
EP18745613.2A EP3645484B1 (en) 2017-07-28 2018-07-26 Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis
CA3070021A CA3070021A1 (en) 2017-07-28 2018-07-26 Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis
KR1020207005703A KR20200035097A (en) 2017-07-28 2018-07-26 Method for producing alkylated or fluoro, chloro and fluorochloroalkylated compounds by heterogeneous cobalt catalysis

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP17020321.0 2017-07-28
EP17020321 2017-07-28
US201762540656P 2017-08-03 2017-08-03
US62/540656 2017-08-03
EP18173211.6 2018-05-18
EP18173211 2018-05-18
EP18179739 2018-06-26
EP18179739.0 2018-06-26

Publications (1)

Publication Number Publication Date
WO2019020726A1 true WO2019020726A1 (en) 2019-01-31

Family

ID=65040004

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/070242 WO2019020726A1 (en) 2017-07-28 2018-07-26 Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis

Country Status (1)

Country Link
WO (1) WO2019020726A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022529074A (en) * 2019-06-12 2022-06-16 アークサーダ・アー・ゲー Fluoroalkylation method of enamine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114359A1 (en) 1982-12-23 1984-08-01 Hoechst Aktiengesellschaft Process for preparing perfluoroalkyl-substituted carbocyclic or heterocyclic compounds
WO1993016969A1 (en) 1992-02-28 1993-09-02 E.I. Du Pont De Nemours And Company Polyfluoroalkylation of aromatic compounds
EP1947092A1 (en) 2005-11-09 2008-07-23 Tosoh Corporation Nucleic acid base having perfluoroalkyl group and method for producing the same
WO2015185677A1 (en) 2014-06-06 2015-12-10 Lonza Ltd Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous catalysis
WO2016071425A1 (en) * 2014-11-07 2016-05-12 Lonza Ltd Method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous catalysis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114359A1 (en) 1982-12-23 1984-08-01 Hoechst Aktiengesellschaft Process for preparing perfluoroalkyl-substituted carbocyclic or heterocyclic compounds
WO1993016969A1 (en) 1992-02-28 1993-09-02 E.I. Du Pont De Nemours And Company Polyfluoroalkylation of aromatic compounds
EP1947092A1 (en) 2005-11-09 2008-07-23 Tosoh Corporation Nucleic acid base having perfluoroalkyl group and method for producing the same
WO2015185677A1 (en) 2014-06-06 2015-12-10 Lonza Ltd Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous catalysis
WO2016071425A1 (en) * 2014-11-07 2016-05-12 Lonza Ltd Method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous catalysis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 1333-86-4
WESTERHAUS ET AL., NATURE CHEMISTRY, vol. 5, 2013, pages 537 - 543

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022529074A (en) * 2019-06-12 2022-06-16 アークサーダ・アー・ゲー Fluoroalkylation method of enamine
JP7208420B2 (en) 2019-06-12 2023-01-18 アークサーダ・アー・ゲー Methods for fluoroalkylating enamines
US11739066B2 (en) 2019-06-12 2023-08-29 Arxada Ag Method for fluoroalkylation of enamines

Similar Documents

Publication Publication Date Title
EP3645484B1 (en) Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis
JP6203431B2 (en) Process for preparing alkylated or fluoro, chloro and fluorochloroalkylated compounds by heterogeneous catalysis
WO2019020726A1 (en) Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis
TW201630852A (en) Method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous catalysis
JP7075544B2 (en) Methods for Preparing Fluoroalkylated Compounds with Uniform Ni Catalysis
Das et al. Nucleophilic reactivity and electrocatalytic reduction of halogenated organic compounds by nickel o-phenylenedioxamidate complexes
WO2013081034A1 (en) Halogenation catalyst and method for producing same
US11332456B2 (en) Method for preparation of fluoro alkylated 1,4-dioxene by homogeneous Ni catalysis
CN111170917B (en) Preparation method of nitrogen-containing heterocyclic compound
WO2019106198A1 (en) Process for the preparation of dihalobenzophenones, new chemicals useful for its implementation and methods for preparing said chemicals
CN111417641A (en) Novel cycloadduct precursors of dihalobenzophenones and their preparation
Popovs Synthetic and Methodological Studies in Copper and Palladium–Catalyzed Carbon-Carbon and Carbon-Heteroatom Bond Formation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18745613

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3070021

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2020504193

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018745613

Country of ref document: EP

Effective date: 20200128

ENP Entry into the national phase

Ref document number: 20207005703

Country of ref document: KR

Kind code of ref document: A